{"id":"W2601521858","doi":"10.1002/psp4.12182","title":"Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Eli Lilly and Company; Galderma; Astellas Pharma; Mylan; UCB Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Meiji Seika Pharma","keywords":"Tofacitinib; Janus kinase inhibitor; Plaque psoriasis; Medicine; Psoriasis; Potency; Body weight; Internal medicine; Psoriasis Area and Severity Index; Population; Pharmacology; Body surface area; Janus kinase; Clinical trial; Dermatology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004345114,0.000438356,0.001075854,0.0006535272,0.0007770499,0.00008681908,0.000930296,0.0003745269,0.00008951327],"category_scores_gemma":[0.0005991624,0.0003366876,0.0001808644,0.0004868265,0.0008098794,0.0004752318,0.000294155,0.0004225179,0.00001794169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001143268,"about_ca_system_score_gemma":0.000167636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000808712,"about_ca_topic_score_gemma":0.00001650218,"domain_scores_codex":[0.9956334,0.001763975,0.001047077,0.0007014722,0.0001347314,0.0007193291],"domain_scores_gemma":[0.9961444,0.001849468,0.0009881449,0.0005907154,0.0003255895,0.0001016483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006755576,0.0009873749,0.05413536,0.0004798181,0.001275351,0.00005841937,0.001111596,0.000629386,0.9111189,0.001312259,0.00105879,0.02107723],"study_design_scores_gemma":[0.1729874,0.00226233,0.1233683,0.0002506187,0.003905615,0.0003259612,0.0006000001,0.007524984,0.6570754,0.0003740822,0.02954891,0.001776446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834579,0.008712418,0.00006416512,0.0002355469,0.004496625,0.002339524,0.0005087777,0.00004961812,0.0001354576],"genre_scores_gemma":[0.9972733,0.0009730529,0.0001972397,0.0001358185,0.0002625383,0.0008314471,0.0001036663,0.00003610288,0.0001868035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2540435,"threshold_uncertainty_score":0.9999085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0632394518170323,"score_gpt":0.3818505316231269,"score_spread":0.3186110798060946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}